Neurogate Therapeutics Inc logo

Neurogate Therapeutics Inc.

Neurogate Therapeutics, is a North Carolina based company with compounds in advanced pre-clinical development for the treatment of epilepsy and neuropathic pain.

NeuroGate Therapeutics is a spinout from the University of North Carolina at Chapel Hill, with its lead compounds developed in the laboratory of Harold Kohn (the inventor of lacosamide).

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Website
Founded2011
Disease Focus
Development StagePreclinical
STOCK CODENon Listed
Address
Raleighu
United States
Email
Contact Number
+1 919-619-4532

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

In 2012, Neurogate was awarded with $248,926.00 SBIR STTR phase I funding for Extended NeuroAmides, Novel Antiepileptic Drug Candidates for the treatment of epilepsy.